DIN 02564963 — APO-MIRABEGRON 25 MG
APO-MIRABEGRON is a tablet (extended-release) of Mirabegron marketed by APOTEX INC. The full Mirabegron monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02564963
- Brand name
- APO-MIRABEGRON
- Active ingredient
- Mirabegron
- Strength
- 25 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Selective beta-3 adrenoceptor agonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Mirabegron products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02564971 | APO-MIRABEGRON | 50 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02564955 | AURO-MIRABEGRON | 50 MG | TABLET (EXTENDED-RELEASE) | AURO PHARMA INC | MARKETED |
| 02402874 | MYRBETRIQ | 25 MG | TABLET (EXTENDED-RELEASE) | ASTELLAS PHARMA CANADA INC | MARKETED |
| 02402882 | MYRBETRIQ | 50 MG | TABLET (EXTENDED-RELEASE) | ASTELLAS PHARMA CANADA INC | MARKETED |